Research Comparison
BPC-157 vs Dermorphin
A side-by-side research comparison of BPC-157 and Dermorphin drawn from Cobalt Peptides' peptide database records.
BPC-157
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a naturally occurring protective protein found in human gastric juice. It has been extensively studied for its regenerative, cytoprotective, and anti-inflammatory properties across multiple tissue types. Research has focused on its ability to accelerate healing in tendons, ligaments, muscles, and gastrointestinal tissues. Its mechanisms involve modulation of angiogenesis, collagen synthesis, and growth factor signaling, making it a broadly acting repair peptide with both local and systemic effects.
Dermorphin
Dermorphin is a naturally derived heptapeptide originally isolated from the skin of South American tree frogs (Phyllomedusa species). It is a highly potent and selective μ-opioid receptor agonist, exhibiting significantly greater affinity and efficacy than endogenous opioid peptides such as endorphins. A unique structural feature of dermorphin is the presence of a D-alanine residue, which enhances receptor binding affinity and resistance to enzymatic degradation. In research settings, dermorphin is used to study opioid receptor signalling, pain modulation pathways, and peptide-receptor interactions.